Ligand-gated liposomes for target responsive drug delivery (PinPoint)
Description of the granted funding
Antimicrobial resistant challenges us in treating chronic infections. Patients suffering from chronic infections such as pneumonia, chronic wound infections, tuberculosis (TB) and cystic fibrosis often need frequent and high-dose antibiotics for long period of their life. Most of antibiotics have severe side effects and low drug efficiency. A drug delivery system capable of carrying the drug to exact target can minimize side effects and decrease antibiotic resistance. This project intends to develop target-gated liposomes capable of finding the bacteria and releasing antibiotics in response. Liposomes will be composed of pH-sensitive lipids and will have a gated cation transporter in their wall which opens only when it binds to the bacteria. When the transporter opens, cations flow into liposomes and cause a pH drop in the liposomes, leading to conformational change of lipids and disrupting the liposome' wall and finally drug release.
Show moreStarting year
2024
End year
2028
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Decision maker
Scientific Council for Natural Sciences and Engineering
13.06.2024
13.06.2024
Other information
Funding decision number
361647
Fields of science
Nanotechnology
Research fields
Nanotiede ja -tekniikka
Identified topics
microbiome, microbiology